panniculitis: a group of diseases whose hallmark is inflammation of subcutaneous adipose tissue (the fatty layer under the skin - panniculus adiposus). Symptoms include tender skin nodules, and systemic signs such as weight loss and fatigue.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
375 |
4. Check minimum number of eventsNone |
375 |
5. Include endpointsNone |
375 |
6. Filter based on genotype QC (FinnGen only) |
375 |
Control definitions (FinnGen only)
- Control exclude
- M13_SOFTTISSUE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M79
- Name in latin
- Panniculitis non specificata
Similar endpoints
↥List of similar endpoints to
Panniculitis, unspecified
based on the number of shared cases.
Similar with more cases:
- Other soft tissue disorders, not elsewhere classified
- Soft tissue disorders
- Pain (limb, back, neck, head abdominally)
- Diseases of the musculoskeletal system and connective tissue
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2209 | 1489 | 709 |
| Only index persons | 2001 | 1370 | 631 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.02 |
| Only index persons | 0.04 | 0.05 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 58.09 | 58.14 | 57.96 |
| Only index persons | 57.31 | 57.27 | 57.40 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 375 | 251 | 124 |
| Unadjusted period prevalence (%) | 0.08 | 0.09 | 0.05 |
| Median age at first event (years) | 57.53 | 54.83 | 63.01 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 342
- Matched controls
- 3420
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M79.3
ICD-10 Finland
Panniculitis, unspecified
4503599627370496.0
323.0
330
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
11.3
53.7
110
138
L52
ICD-10 Finland
Erythema nodosum
244.9
42.9
43
*
M79.6
ICD-10 Finland
Pain in limb
4.1
28.1
139
487
H02AB06
ATC
prednisolone; systemic
3.2
22.7
197
1030
A46
ICD-10 Finland
Erysipelas
4.7
21.8
81
210
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
6.0
21.4
62
121
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.9
20.6
73
179
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
20.1
179
925
P01BA02
ATC
hydroxychloroquine; oral
5.9
20.0
59
117
M75.1
ICD-10 Finland
Rotator cuff syndrome
4.2
19.1
79
226
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.2
18.5
77
221
M79.0
ICD-10 Finland
Rheumatism, unspecified
52.9
17.2
20
*
N02AX02
ATC
tramadol; systemic, rectal
2.7
16.8
163
853
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.5
16.6
89
314
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.9
16.0
122
549
E66.8
ICD-10 Finland
Other obesity
7.4
15.8
38
57
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.2
15.7
64
178
7293X
ICD-9 Finland
Other disorders of soft tissues, Panniculitis, unspecified[PANNICULITIS NUD]
+∞
15.7
15
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.7
15.4
144
730
N03AX12
ATC
gabapentin; oral
3.9
15.0
67
203
A02BC02
ATC
pantoprazole; systemic
2.6
14.8
235
1581
D07AC01
ATC
betamethasone; topical
2.6
14.6
141
721
J01FF01
ATC
clindamycin; systemic
2.8
14.1
108
480
R50.9
ICD-10 Finland
Fever, unspecified
3.7
14.0
66
208
J01DB01
ATC
cefalexin; oral
2.9
13.7
287
2200
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
4.4
13.6
51
131
M79.7
ICD-10 Finland
Fibromyalgia
19.2
13.5
20
11
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.5
13.5
139
732
E0000UV
ATC
NA
2.4
13.1
159
907
M25.5
ICD-10 Finland
Pain in joint
2.7
12.7
103
469
N03AX16
ATC
pregabalin; oral
2.9
12.7
90
377
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
4.1
12.2
49
134
N02AJ06
ATC
codeine and paracetamol; systemic
2.4
12.2
132
706
M13.9
ICD-10 Finland
Arthritis, unspecified
5.1
12.1
38
81
X59
ICD-10 Finland
Exposure to unspecified factor
3.1
12.1
74
281
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
11.1
11.9
22
21
C03CA01
ATC
furosemide; systemic
2.5
11.8
111
548
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
14.3
11.6
19
14
L88
ICD-10 Finland
Pyoderma gangrenosum
+∞
11.5
11
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.2
11.5
65
235
ZXA00
NOMESCO Finland
Right side
2.5
11.3
102
489
L04AX01
ATC
azathioprine; systemic
5.7
11.2
32
61
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.3
11.1
41
104
TQW80
NOMESCO Finland
Local dermatologic skincare
8.2
11.1
24
31
J01DA01
ATC
[U] cefalexin; systemic
2.2
11.0
224
1578
D07AD01
ATC
clobetasol; topical
2.9
11.0
73
293
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
4.2
11.0
42
110
J01MA02
ATC
ciprofloxacin; systemic
2.3
10.9
145
842
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
10.1
10.9
21
22
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.7
10.9
37
86
R03AC02
ATC
salbutamol; inhalant
2.2
10.8
183
1187
P01AB01
ATC
metronidazole; oral, rectal
2.2
10.7
147
866
SPAT1263
SPAT
Sampling
2.2
10.7
154
928
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
62.0
10.7
12
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.2
10.6
152
912
SPAT1153
SPAT
Removal of sutures
2.3
10.4
121
659
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
13.7
10.3
17
13
S18
ICPC
Laceration/cut
2.2
10.2
149
896
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.8
10.1
69
281
S97
ICPC
Chronic ulcer skin
4.8
10.0
33
75
A18.4
ICD-10 Finland
Tuberculosis of skin and subcutaneous tissue
+∞
9.4
9
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.7
9.4
72
311
UJF32
NOMESCO Finland
Coloscopy
2.3
9.4
103
542
R51.80
ICD-10 Finland
Headache
3.0
9.4
56
207
ZXA05
NOMESCO Finland
Left side
2.3
9.3
97
497
T90
ICPC
Diabetes non-insulin dependent
2.4
9.3
91
452
M01AC06
ATC
meloxicam; systemic, rectal
2.1
9.1
123
710
L17
ICPC
Foot/toe symptom/complaint
2.3
9.0
93
474
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
9.0
84
405
N06AX21
ATC
duloxetine; oral
3.5
8.9
42
132
M79.1
ICD-10 Finland
Myalgia
3.4
8.9
43
138
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
8.9
79
370
UJF30
NOMESCO Finland
Ileoscopy through colon
3.2
8.7
48
167
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.2
8.6
45
153
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.2
8.6
45
153
M01AH05
ATC
etoricoxib; oral
2.0
8.6
193
1353
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
7.7
8.6
19
26
B01AB05
ATC
enoxaparin; parenteral
2.1
8.4
112
634
J01MA12
ATC
levofloxacin; systemic
2.5
8.4
72
333
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
7.9
8.3
18
24
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.3
8.3
90
467
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.0
8.2
47
170
M79.9
ICD-10 Finland
Soft tissue disorder, unspecified
34.2
8.1
10
*
R42
ICD-10 Finland
Dizziness and giddiness
2.3
8.1
81
403
I10
ICD-10 Finland
Essential (primary) hypertension
1.9
8.1
199
1430
M67.4
ICD-10 Finland
Ganglion
5.7
8.0
22
41
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.4
7.9
69
320
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
7.9
130
804
Z3231
NOMESCO Finland
Registered nurse
2.2
7.9
95
516
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
7.7
90
481
M76.6
ICD-10 Finland
Achilles tendinitis
6.0
7.6
20
35
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
12.2
7.6
13
11
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.9
7.6
30
82
H02AB07
ATC
prednisone; oral
2.7
7.5
53
217
A02BC01
ATC
omeprazole; systemic
2.1
7.5
99
555
WX002
NOMESCO Finland
Sedation and analgesia
2.3
7.5
73
358
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.1
7.5
92
501
J45.8
ICD-10 Finland
Mixed asthma
7.1
7.4
17
25
A08
ICPC
Swelling
5.4
7.4
21
41
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.6
7.4
32
95
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.1
7.3
100
570
D07AC13
ATC
mometasone; topical
2.0
7.1
106
624
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
5.4
7.1
20
39
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
7.0
41
151
A02BC05
ATC
esomeprazole; systemic
1.9
7.0
140
918
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
4.6
7.0
23
53
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.4
7.0
24
58
E66.9
ICD-10 Finland
Obesity, unspecified
5.2
6.9
20
40
E000001
ATC
NA
2.2
6.9
81
430
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
4.3
6.8
24
59
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.3
6.8
33
107
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
40.9
6.8
8
*
NDM20
NOMESCO Finland
Excision of synovial ganglion of wrist or hand
40.9
6.8
8
*
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
17.1
6.8
10
6
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
17.1
6.8
10
6
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.4
6.8
32
102
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.4
6.7
19
37
J01FA06
ATC
roxithromycin; oral
1.9
6.7
139
917
M01AE01
ATC
ibuprofen; systemic, rectal
2.3
6.7
301
2611
L08
ICPC
Shoulder symptom/complaint
2.4
6.7
59
275
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.8
6.7
27
76
M02AA07
ATC
piroxicam; topical
1.9
6.6
123
783
R03BA02
ATC
budesonide; inhalant
2.3
6.6
65
319
103
Kela drug reimbursment
Diabetes, insulin-treated
2.0
6.5
96
559
A01AB09
ATC
miconazole; local oral
2.9
6.5
39
147
J45.9
ICD-10 Finland
Asthma, unspecified
2.2
6.5
65
323
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
6.5
58
273
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
5.4
6.4
18
35
L86
ICPC
Back syndrome with radiating pain
4.8
6.4
20
44
SPAT1262
SPAT
Handing over of treatment supplies
2.2
6.4
70
361
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.1
6.4
34
119
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
6.4
55
254
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
9.5
6.3
12
13
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.8
6.3
38
144
C07AB07
ATC
bisoprolol; oral
1.8
6.3
151
1043
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.2
6.3
68
350
N06AA09
ATC
amitriptyline; systemic
2.8
6.2
39
148
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
6.2
82
456
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.0
6.2
82
458
A10AE04
ATC
insulin glargine; parenteral
2.8
6.2
39
150
J01DA09
ATC
[U] cefadroxil; inhalant, oral
2.0
6.2
92
539
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.3
6.2
59
287
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.5
6.2
49
217
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.7
6.1
40
159
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.9
6.1
96
571
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
6.1
90
525
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
12.8
6.1
10
8
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
6.1
53
245
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
6.2
6.1
15
25
M48.0
ICD-10 Finland
Spinal stenosis
2.7
6.0
40
161
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.0
6.0
32
112
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768443) Skin Pathology biopsy report
67
118
6.70
37.92
1.4
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
36
29
13.63
37.17
1.6
3.0
g/l
0.6
1.3
0.61
30
24
(3013115) Eosinophils [#/volume] in Blood
265
1424
3.94
33.62
10.3
5.8
e9/l
0.2
0.2
0.29
244
1262
(3001604) Monocytes [#/volume] in Blood
257
1367
3.80
32.81
9.9
5.6
e9/l
0.6
0.6
0.77
238
1187
(3006315) Basophils [#/volume] in Blood
257
1376
3.76
32.27
10.0
5.6
e9/l
0.0
0.0
0.31
238
1201
(3019198) Lymphocytes [#/volume] in Blood
260
1405
3.77
32.12
10.0
5.6
e9/l
1.9
2.0
0.29
242
1242
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
52
85
6.94
31.42
1.5
1.6
iu/ml
0.2
0.1
0.12
17
17
(3037522) Nuclear Ab [Titer] in Serum
109
340
4.11
31.25
1.6
1.3
titre
329.3
524.2
0.86
30
67
(3022096) Basophils/100 leukocytes in Blood
231
1247
3.22
26.74
10.2
5.7
%
0.7
0.7
0.28
221
1158
(3006504) Eosinophils/100 leukocytes in Blood
234
1290
3.16
25.78
10.2
5.7
%
2.8
2.8
0.09
223
1196
(3013650) Neutrophils [#/volume] in Blood by Automated count
273
1651
3.40
25.50
13.0
9.2
e9/l
4.4
4.1
1.25
254
1447
(3019069) Monocytes/100 leukocytes in Blood
234
1298
3.14
25.35
10.6
6.0
%
8.9
8.6
0.63
224
1213
(3018010) Neutrophils/100 leukocytes in Blood
234
1313
3.08
24.55
10.0
5.6
%
57.3
57.2
0.06
225
1230
(3002030) Lymphocytes/100 leukocytes in Blood
236
1333
3.08
24.42
10.4
5.8
%
28.3
28.1
0.07
226
1241
(3023368) Bacteria identified in Blood by Culture
155
696
3.09
24.26
5.8
4.0
—
—
—
0
0
(4062490)
22
16
14.54
23.84
1.5
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
181
894
2.98
23.76
9.8
5.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
149
673
3.01
22.83
3.2
2.6
umol/l
359.2
9018.9
3.76
129
574
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
239
1411
2.91
21.88
8.5
6.6
mmol/l
1.2
1.2
0.55
210
1176
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
43
84
5.65
21.54
2.0
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
125
552
2.90
19.47
4.0
2.7
mosm/kgh2o
581.9
553.9
0.68
112
464
(3024561) Albumin [Mass/volume] in Serum or Plasma
215
1250
2.69
19.46
6.2
4.5
g/l
34.1
35.7
3.79
201
1162
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
241
1492
2.72
19.05
7.6
6.3
umol/l
9.7
11.4
3.08
231
1407
(3007853) Bacteria identified in Skin by Aerobe culture
83
299
3.28
18.35
2.2
1.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
313
2261
3.32
17.78
12.2
7.1
u/l
78.4
78.4
0.00
302
2103
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
156
809
2.59
17.37
2.5
2.0
u/l
138.5
238.0
1.45
151
750
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
180
1002
2.53
17.21
4.5
2.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
215
1306
2.51
16.94
15.2
9.1
e9/l
0.0
0.0
0.11
191
1085
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
16
12
13.88
16.89
1.6
3.8
u/ml
1898.3
740.9
0.56
16
12
(3018095) Leukocytes [#/volume] in Urine
178
1013
2.44
15.89
4.9
3.3
e6/l
23.2
93.1
4.11
143
724
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
208
1269
2.44
15.88
7.0
5.8
mmol/l
1.2
1.2
0.17
203
1143
(3013707) Erythrocyte sedimentation rate by Westergren method
298
2160
2.85
15.52
7.9
3.7
mm/h
18.2
12.2
6.47
283
1972
(3002582) Erythrocytes [#/volume] in Urine
158
860
2.45
15.47
4.1
2.9
e6/l
14.5
73.0
2.46
135
667
(3048689) Calprotectin [Mass/mass] in Stool
82
327
2.93
15.02
2.3
2.4
ug/g
99.7
124.2
0.53
67
255
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
212
1326
2.38
15.01
4.7
4.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
159
878
2.41
14.97
4.5
2.2
u/l
83.4
58.1
0.39
150
803
(3025159) Blasts/100 leukocytes in Blood
62
215
3.26
14.41
6.2
4.2
%
0.1
0.1
0.18
12
56
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
34
77
4.76
14.33
2.5
2.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
61
214
3.21
13.89
2.2
2.9
g/l
65.8
67.2
0.62
54
196
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
99
457
2.58
13.55
1.4
1.2
iu/ml
38.1
37.7
0.01
26
150
(3021440) Promyelocytes/100 leukocytes in Blood
63
229
3.10
13.50
6.3
4.1
%
0.1
0.1
0.27
14
64
(3030467) Casts [#/volume] in Urine by Automated count
143
783
2.34
13.43
3.6
2.8
e6/l
0.3
0.5
1.59
122
592
(3017181) Myelocytes/100 leukocytes in Blood
66
248
3.02
13.35
6.1
4.0
%
0.5
1.0
1.00
14
75
(40760892) CBC W Ordered Manual Differential panel - Blood
126
657
2.38
13.20
7.9
4.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
116
589
2.40
12.86
3.1
2.4
e6/l
4.1
7.0
1.24
101
515
(3022948) Iron [Moles/volume] in Serum or Plasma
94
434
2.56
12.79
2.8
2.3
umol/l
11.2
13.1
1.74
89
398
(3037467) Urinalysis macro (dipstick) panel - Urine
276
2011
2.41
12.75
6.9
4.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
83
363
2.65
12.60
2.9
2.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
53
181
3.25
12.58
2.2
1.7
g/l
1.4
1.4
0.05
48
162
(3004588) Protein electrophoresis panel - Serum or Plasma
54
188
3.19
12.41
2.4
2.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
110
559
2.37
12.07
1.8
1.4
g/l
2.7
2.4
0.35
73
351
(3032080) INR in Blood by Coagulation assay
182
1137
2.17
12.07
14.4
9.5
inr
1.3
1.2
0.33
45
346
(3026008) Bacteria identified in Urine by Culture
154
904
2.19
11.93
4.1
2.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
19
30
6.62
11.66
1.1
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
239
1675
2.18
11.61
5.8
4.6
mmol/l
7.1
6.7
1.71
232
1554
(3002179) Metamyelocytes/100 leukocytes in Blood
58
219
2.95
11.57
6.0
3.9
%
0.7
0.6
0.18
11
52
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
90
427
2.46
11.44
1.4
1.2
u/ml
17.9
12.9
0.19
29
162
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
185
1182
2.12
11.38
3.0
2.2
nmol/l
76.0
77.5
0.31
171
1063
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
112
590
2.28
11.20
1.9
1.6
mg/l
0.8
1.2
2.26
92
455
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
52
188
3.05
11.18
1.7
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
23
46
5.26
11.14
1.8
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
178
1129
2.10
11.07
2.3
1.9
pmol/l
95.7
96.6
0.09
111
572
(3009508) Creatinine [Moles/volume] in Urine
148
879
2.13
10.92
3.3
2.9
mmol/l
6.7
7.5
1.40
121
743
(40758558) Short blood count panel - Blood
126
704
2.19
10.86
8.8
6.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
170
1068
2.08
10.77
4.4
3.4
ng/l
37.6
43.2
0.14
121
726
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
80
369
2.48
10.76
2.9
2.4
%
20.4
23.2
0.81
68
310
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
152
919
2.10
10.64
3.6
3.1
u/l
29.6
30.8
0.31
147
881
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
62
254
2.73
10.60
3.8
2.0
u/l
30.2
32.2
0.25
53
222
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
97
3.75
10.59
2.8
1.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
97
3.75
10.59
2.8
1.9
g/l
7.7
7.4
0.36
25
74
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
97
3.75
10.59
2.8
1.9
g/l
3.6
3.8
0.38
24
71
(36304419) Bacteria [Presence] in Urine
131
751
2.14
10.52
3.4
2.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
153
932
2.08
10.46
2.8
2.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
141
833
2.11
10.46
3.4
3.0
mg/l
520.5
218.4
0.27
85
507
(3035350) Ketones [Presence] in Urine by Test strip
208
1417
2.05
10.46
6.0
3.6
estimate
0.0
0.0
0.00
45
267
(3020682) Albumin/Creatinine [Ratio] in Urine
147
886
2.08
10.31
4.4
3.8
mg/mmol
8.2
8.6
0.04
95
541
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
90
3.79
10.17
2.9
1.9
g/l
3.2
3.0
0.49
26
73
(3036481) Cortisol [Moles/volume] in Serum or Plasma
58
237
2.71
9.95
2.3
1.8
nmol/l
319.5
380.7
1.76
53
216
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
86
426
2.32
9.81
1.8
1.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
157
986
2.02
9.71
3.2
3.4
mmol/l
2.3
2.4
0.98
145
877
(3018418) pH of Serum or Plasma
141
859
2.03
9.43
4.6
3.7
ph
7.4
7.4
1.08
32
164
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
67
302
2.48
9.40
3.6
2.8
umol/l
4.9
7.8
2.68
61
263
(3021601) Nitrite [Presence] in Urine by Test strip
205
1428
1.96
9.27
7.5
4.8
estimate
0.0
0.0
0.00
47
266
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
86
438
2.25
9.13
3.4
2.7
e6/l
3.5
2.7
0.32
59
241
(3009261) Glucose [Presence] in Urine by Test strip
206
1442
1.95
9.13
6.1
3.5
estimate
0.0
0.0
0.00
47
258
(3025941) Bacteria identified in Stool by Culture
40
140
3.08
9.07
1.5
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
91
478
2.19
8.95
2.4
2.5
e6/l
1.4
1.1
0.33
62
278
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
26
69
3.97
8.94
1.3
1.2
—
3.4
—
0
11
(3042631) Mycobacterium sp identified in Specimen
16
29
5.72
8.57
3.4
3.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
66
308
2.39
8.55
1.4
1.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
184
1264
1.89
8.40
3.9
2.7
ug/l
131.9
124.8
0.15
173
1153
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
116
686
2.00
8.25
3.2
2.1
mg/l
3.4
3.1
0.38
106
579
(3019309) Folate [Moles/volume] in Red Blood Cells
92
502
2.10
8.14
2.1
1.7
nmol/l
1178.5
1215.4
0.16
82
367
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
26
75
3.65
7.97
1.5
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
25
71
3.70
7.84
1.2
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
41
158
2.79
7.83
1.2
1.2
u/ml
89.3
338.0
0.95
35
144
(3022217) INR in Platelet poor plasma by Coagulation assay
68
335
2.26
7.74
32.7
21.0
inr
1.2
1.2
—
7
48
(46235355) HIV 1 and 2 tests - Meaningful Use set
87
474
2.09
7.69
1.7
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
42
167
2.71
7.56
6.0
7.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
122
758
1.90
7.39
6.9
4.0
estimate
0.0
0.0
0.00
45
259
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
125
792
1.87
7.08
3.3
3.1
ng/l
1468.2
1534.4
0.06
113
663
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
164
1130
1.80
7.06
6.2
3.8
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
114
705
1.89
6.94
5.0
3.6
%
93.8
92.0
0.25
114
688
(3003396) Base excess in Arterial blood by calculation
61
301
2.23
6.89
6.6
9.0
mmol/l
1.3
1.6
0.35
53
245
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
248
1944
1.81
6.78
3.9
2.9
u/l
49.4
49.9
0.03
236
1808
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
326
2799
2.26
6.78
5.9
4.4
mu/l
1.9
1.9
0.20
311
2524
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
16
36
4.60
6.77
1.4
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
17
41
4.30
6.62
3.4
3.0
e9/l
4.0
4.1
0.08
17
41
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
37
148
2.66
6.59
4.2
3.3
mmol/l
1.7
1.9
0.11
25
111
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
80
3.28
6.57
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
80
3.28
6.57
1.3
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
342
3007
2.56
6.55
27.8
12.5
mg/l
22.8
23.9
0.24
307
2309
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
18
6.27
6.46
1.6
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
18
6.27
6.46
1.6
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
18
6.27
6.46
1.6
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
18
6.27
6.46
1.6
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
18
6.27
6.46
1.6
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
18
6.27
6.46
1.6
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
25
81
3.24
6.44
1.3
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
38
156
2.60
6.43
4.2
3.2
ph
7.4
7.4
—
7
18
(3027945) Reticulocytes/100 erythrocytes in Blood
60
303
2.17
6.39
2.7
2.7
%
2.1
1.8
0.93
52
266
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
21
61
3.59
6.38
2.1
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
282
2326
1.86
6.21
4.8
3.7
pmol/l
15.1
14.7
1.44
268
2077
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
108
677
1.84
6.21
2.7
2.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
72
394
2.02
6.21
1.5
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
83
479
1.94
6.15
1.6
1.5
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
10
8
12.80
6.11
1.0
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
36
148
2.58
6.07
1.7
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
57
288
2.15
6.06
1.6
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
100
618
1.84
5.99
6.5
4.0
kg/l
1.0
1.0
0.31
16
84
(3042111) Morphology [Interpretation] in Bone marrow Narrative
18
49
3.81
5.99
1.3
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
21
64
3.42
5.95
1.5
1.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
54
269
2.18
5.94
3.2
3.3
kpa
5.7
5.7
0.09
54
260
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
30
114
2.77
5.89
1.6
1.7
g/l
1.4
1.5
0.40
25
98
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
17
45
3.91
5.88
3.4
3.2
%
56.9
58.3
0.14
17
45
(3019550) Sodium [Moles/volume] in Serum or Plasma
349
3129
2.66
5.83
26.6
14.6
mmol/l
139.6
139.8
0.62
344
3034
(3023103) Potassium [Moles/volume] in Serum or Plasma
350
3143
2.70
5.81
27.0
14.7
mmol/l
4.0
4.0
0.14
345
3042
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
55
3.59
5.81
1.7
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
98
609
1.82
5.75
1.4
1.2
u/ml
1.0
2.1
0.72
32
164
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
56
290
2.09
5.58
1.6
1.8
—
—
—
0
0
(3012544) pH of Venous blood
54
276
2.12
5.57
3.3
3.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
40
182
2.34
5.45
2.1
2.7
e9/l
3.4
3.8
0.75
33
147
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
24
85
2.95
5.35
1.7
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
122
824
1.71
5.32
5.3
3.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
163
1193
1.65
5.21
2.4
2.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
65
3.19
5.14
1.5
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
320
2809
1.95
5.04
8.3
5.4
mmol/mol
41.9
39.6
3.52
306
2595
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
227
1819
1.63
4.94
2.8
2.9
—
—
—
0
0
(3044889) 12 lead EKG panel
258
2135
1.67
4.93
4.4
3.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
59
326
1.96
4.92
1.9
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
45
225
2.14
4.91
2.6
3.0
e9/l
73.2
67.9
0.39
34
171
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
20
67
3.10
4.90
1.2
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
81
497
1.80
4.89
4.6
3.6
ng/l
36.4
268.5
2.36
61
389
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
88
554
1.77
4.87
2.9
2.7
mmol/l
2.5
2.5
0.80
80
496
(3004716) Salmonella sp identified in Stool by Organism specific culture
33
145
2.40
4.86
1.3
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
28
114
2.57
4.84
3.3
3.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
36
165
2.31
4.83
4.6
2.5
e6/l
0.2
0.2
0.12
36
158
(3013512) EKG study
123
852
1.66
4.80
5.8
3.6
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
45
227
2.12
4.80
3.0
2.7
kpa
4.1
4.5
1.06
45
217
(3000475) Leukocytes [#/volume] in Synovial fluid
19
63
3.12
4.74
2.0
1.8
e6/l
10937.9
20067.2
0.44
14
49
(40761535) Cells panel - Urine sediment
44
223
2.10
4.64
5.0
3.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
41
203
2.14
4.58
1.4
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
49
3.37
4.52
1.0
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
15
44
3.51
4.51
1.7
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
15
44
3.51
4.51
1.3
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
17
55
3.19
4.42
3.4
2.1
g/l
131.1
133.5
—
10
40
(3045142) Bone marrow Pathology biopsy report
13
35
3.81
4.40
1.2
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
45
235
2.04
4.39
3.1
3.0
ng/l
82.5
79.7
0.07
38
208
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
15
45
3.43
4.37
1.0
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
353
3248
2.48
4.36
18.1
9.6
u/l
26.5
25.0
0.93
347
3113
(3045414) Leukocytes [Presence] in Urine
27
114
2.47
4.34
2.2
1.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
24
96
2.60
4.30
4.9
4.5
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
34
161
2.22
4.24
5.9
9.3
%
94.5
93.8
0.53
34
161
(40760888) Immunoglobulin light chains.free panel - Serum
19
68
2.89
4.18
2.2
4.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
347
3181
2.22
4.14
23.5
12.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
43
226
2.02
4.12
5.5
8.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
19
69
2.85
4.08
1.6
1.9
u/l
21.1
1136.9
—
8
25
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
14
42
3.42
4.08
1.0
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
14
42
3.42
4.08
1.6
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
32
151
2.22
4.03
1.8
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
28
4.02
4.00
1.9
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
11
28
4.02
4.00
1.9
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
11
28
4.02
4.00
1.9
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
16
54
3.05
3.89
1.7
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
11
29
3.88
3.83
1.9
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
29
3.88
3.83
1.9
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
29
3.88
3.83
1.9
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
14
44
3.27
3.81
1.0
1.1
u/ml
149.8
225.2
—
9
26
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
94
641
1.62
3.80
1.9
1.7
pmol/l
473.3
442.2
0.42
81
538
(3002256) Pathology report gross observation
64
394
1.75
3.79
1.4
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
25
110
2.36
3.70
1.7
1.8
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
34
171
2.09
3.67
2.5
2.4
—
16.6
—
0
8
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
52
304
1.82
3.65
4.6
3.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
18
69
2.69
3.52
1.1
1.3
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
8
13
6.26
3.52
1.9
2.3
ug/l
56.4
62.6
—
8
13
(3020891) Body temperature
24
107
2.33
3.46
3.8
4.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
63
396
1.71
3.46
1.4
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
320
2894
1.72
3.44
21.9
11.7
ml/min/173m2
79.5
80.5
0.34
292
2356
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
32
3.51
3.36
2.7
2.7
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
6
7
8.69
3.27
1.0
2.1
%
17.7
29.4
—
6
7
(3006245) CD3-CD19+ cells/100 cells in Blood
6
7
8.69
3.27
1.0
2.1
%
12.7
7.3
—
6
7
(3022145) Colonoscopy Study observation
51
307
1.77
3.26
1.2
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
12
38
3.23
3.24
1.1
1.5
u/ml
115.2
104.9
—
5
7
(3038177) Helicobacter pylori Ab [Presence] in Serum
12
38
3.23
3.24
1.3
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
38
3.23
3.24
2.2
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
12
38
3.23
3.24
1.1
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
23
104
2.29
3.23
2.5
3.4
g/l
0.2
0.2
—
10
37
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
15
5.42
3.20
1.3
2.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
10
29
3.52
3.07
2.2
4.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
5
10.11
2.98
1.8
1.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
17
70
2.50
2.92
6.1
2.4
mmol/l
24.1
25.5
0.64
17
58
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
22
4.16
2.90
1.2
1.1
—
—
—
0
0
(3019225) pH of Specimen
44
263
1.76
2.89
4.5
4.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
31
3.29
2.79
1.4
1.0
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
20
91
2.27
2.79
3.7
3.8
—
1.1
—
0
10
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
6
8.42
2.75
1.2
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
16
66
2.49
2.75
1.2
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
14
5.07
2.74
1.3
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
30
162
1.93
2.71
4.6
3.8
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
24
3.82
2.69
2.8
4.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
13
49
2.71
2.65
4.8
2.3
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
7
15
4.73
2.61
1.3
1.1
umol/l
23.0
17.4
—
7
15
(3021960) Folate [Moles/volume] in Serum or Plasma
92
676
1.48
2.59
1.8
1.5
nmol/l
19.0
20.8
0.60
86
569
(36660697) Celiac disease serology panel - Serum
36
211
1.78
2.54
1.3
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
21
102
2.12
2.52
1.7
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
106
805
1.44
2.51
1.7
1.6
mmol/l
1.5
1.4
0.80
96
669
(3028626) Oxygen [Partial pressure] in Capillary blood
15
63
2.44
2.49
4.9
2.5
kpa
8.1
8.2
0.04
15
56
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
25
131
1.97
2.47
10.8
13.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
18
83
2.23
2.45
2.7
2.4
u/ml
0.3
0.3
0.49
13
47
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
22
3.69
2.37
1.0
1.1
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
7
17
4.17
2.37
1.0
2.2
%
104.4
91.4
—
7
17
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
7
17
4.17
2.37
1.1
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
18
85
2.17
2.32
1.6
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
9
28
3.27
2.32
1.1
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
358
3415
2.07
2.31
37.7
18.7
e12/l
4.4
4.5
3.06
351
3305
(3010813) Leukocytes [#/volume] in Blood
358
3415
2.07
2.31
37.7
18.7
e9/l
7.1
6.6
3.70
351
3307
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
13
4.67
2.28
2.2
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
13
4.67
2.28
2.2
1.3
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
6
13
4.67
2.28
1.0
2.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
18
3.94
2.26
1.7
1.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
9
5.61
2.22
1.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
36
2.83
2.22
1.1
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
38
236
1.68
2.21
2.9
2.2
ug/l
4.4
6.9
0.70
32
201
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
16
74
2.21
2.18
1.4
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
14
4.34
2.16
5.3
6.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
8
25
3.25
2.10
1.3
4.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
322
3001
1.52
2.10
5.7
4.2
mmol/l
6.3
5.9
3.47
307
2720
(3011397) Hemoglobin [Presence] in Urine by Test strip
83
622
1.43
2.09
6.2
3.6
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
10
5.05
2.07
1.0
1.0
%
93.6
110.3
—
5
10
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
329
3083
1.55
2.06
5.6
4.7
mmol/l
2.6
2.8
3.26
314
2831
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
15
4.05
2.04
1.0
1.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
12
51
2.40
1.97
2.3
3.1
nmol/l
0.7
1.0
—
7
39
(4306422)
10
39
2.61
1.93
1.1
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
311
2895
1.44
1.88
4.5
3.8
mmol/l
1.4
1.3
2.31
295
2657
(3044290) Cell count panel - Cerebral spinal fluid
9
34
2.69
1.87
1.3
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
19
101
1.93
1.84
1.0
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
12
4.21
1.83
1.0
3.3
%
169.4
118.3
—
5
12
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
12
4.21
1.83
1.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
12
4.21
1.83
2.4
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
12
4.21
1.83
2.4
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
322
3021
1.47
1.82
5.1
4.3
mmol/l
4.5
4.7
4.01
307
2797
(3022806) Fractional oxyhemoglobin in Capillary blood
8
29
2.80
1.80
3.9
2.2
%
92.1
90.7
—
8
29
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
46
316
1.52
1.80
1.5
1.8
%
1.6
1.4
0.70
39
273
(3023511) Choriogonadotropin [Units/volume] in Urine
11
47
2.38
1.79
1.9
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
17
306
0.53
1.78
1.2
1.4
—
—
—
0
0
(4094501)
16
81
2.02
1.77
1.1
1.1
—
—
—
0
0
(3000492) Spirometry study
39
262
1.55
1.69
1.6
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
19
3.19
1.66
1.0
1.2
—
—
—
0
0
(4035726)
42
288
1.52
1.66
1.6
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
319
3002
1.42
1.63
5.0
4.2
mmol/l
1.4
1.5
6.15
304
2762
(3035320) C reactive protein [Mass/volume] in Body fluid
5
14
3.60
1.62
2.4
1.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
14
3.60
1.62
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
24
145
1.70
1.58
3.1
2.3
—
—
—
0
0
(4010399)
31
201
1.59
1.57
1.9
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
185
0.47
1.54
1.4
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
16
280
0.55
1.54
1.6
1.7
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
16
86
1.90
1.52
4.4
3.3
mmol/l
3.8
3.9
0.49
16
80
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
27
2.62
1.52
1.6
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
51
2.19
1.52
1.4
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
51
2.19
1.52
1.4
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
21
2.89
1.51
1.2
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
101
824
1.31
1.48
1.4
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
34
229
1.53
1.48
6.7
3.0
ml/min/173m2
64.7
60.8
0.18
16
95
(3044941) Cell count panel - Synovial fluid
9
39
2.34
1.44
1.2
1.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
22
134
1.68
1.42
1.3
1.1
titre
—
104.2
—
0
5
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
49
359
1.42
1.41
10.7
6.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
37
0.00
1.35
0.0
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
14
76
1.87
1.31
13.0
11.8
mmol/l
1.5
1.3
0.33
14
70
(3023199) Leukocytes [#/volume] in Pleural fluid
6
24
2.52
1.31
1.3
1.2
e6/l
1754.2
1533.1
—
6
18
(3026389) Candida sp identified in Specimen by Organism specific culture
8
34
2.38
1.30
1.6
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
34
2.38
1.30
1.0
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
17
99
1.75
1.29
2.5
2.9
—
—
—
0
0
(1616796) Gas panel - Central venous blood
11
55
2.03
1.28
10.5
2.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
35
2.31
1.27
2.0
2.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
25
2.42
1.25
1.0
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
25
2.42
1.25
1.0
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
25
2.42
1.25
1.0
1.8
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
10
49
2.07
1.23
2.0
2.6
mmol/l
107.1
105.4
—
10
49
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
49
2.07
1.23
2.0
2.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
10
49
2.07
1.23
2.0
2.6
mmol/l
4.0
4.0
—
10
49
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
26
2.33
1.19
1.2
1.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
26
2.33
1.19
1.2
1.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
20
126
1.62
1.17
2.3
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
23
151
1.56
1.14
2.3
1.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
51
1.99
1.12
4.1
2.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
295
2790
1.27
1.10
24.0
13.8
%
37.9
39.8
2.03
194
1994
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
41
1.97
1.09
1.0
1.0
—
—
—
0
0
(4268621)
7
32
2.21
1.08
1.9
2.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
33
2.14
1.06
1.1
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
25
173
1.48
1.00
1.5
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
23
2.19
0.98
1.2
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
34
254
1.37
0.92
5.6
3.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
42
325
1.33
0.91
4.1
4.2
ug/l
3.3
42.7
0.95
35
266
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
14
87
1.63
0.89
1.6
1.4
miu/ml
112.3
237.1
—
6
42
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
43
1.88
0.88
1.0
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
12
73
1.67
0.82
2.7
3.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
47
1.72
0.81
1.0
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
48
1.68
0.79
1.3
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
67
1.66
0.76
1.2
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
54
1.68
0.75
3.0
2.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
54
1.68
0.75
1.3
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
24
2.10
0.75
1.4
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
24
2.10
0.75
1.2
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
87
755
1.20
0.74
4.2
4.7
ug/l
1.6
2.5
1.25
78
665
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
39
1.81
0.73
1.0
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
40
1.76
0.71
1.1
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
19
135
1.43
0.70
1.1
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
61
1.66
0.69
2.3
2.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
42
1.68
0.68
1.3
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
52
432
1.24
0.68
2.6
3.0
ug/l
0.6
0.8
1.39
36
280
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
33
259
1.30
0.68
1.4
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
43
1.64
0.67
1.3
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
28
1.80
0.66
1.2
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
24
181
1.35
0.65
2.2
2.5
u/ml
156.3
52.3
0.51
24
174
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
29
1.73
0.64
1.8
4.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
30
1.68
0.61
2.4
2.4
%
13.6
12.9
—
5
30
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
14
97
1.46
0.60
1.1
1.7
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
26
202
1.31
0.59
1.2
1.2
iu/ml
58.0
148.2
—
9
86
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
37
1.63
0.56
1.2
1.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
37
1.63
0.56
1.0
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
60
1.51
0.54
1.1
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
9
61
1.49
0.54
1.6
1.3
u/l
16.4
11.3
—
9
53
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
62
1.46
0.53
3.1
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
21
162
1.31
0.51
1.5
1.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
10
68
1.48
0.47
2.7
2.4
ug/min
47.2
50.4
—
5
38
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
49
1.44
0.46
1.3
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
68
605
1.15
0.45
3.6
4.2
%
24.5
20.8
1.18
29
279
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
31
1.62
0.43
1.2
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
31
1.62
0.43
1.4
1.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
59
1.36
0.41
1.7
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
34
1.48
0.40
3.0
2.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
103
0.67
0.40
1.3
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
56
497
1.15
0.39
1.4
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
33
280
1.20
0.39
2.1
2.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
98
1.34
0.38
1.7
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
42
1.44
0.35
1.2
1.7
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
43
1.40
0.35
2.3
2.5
pg
32.2
33.6
—
6
43
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
57
1.23
0.29
1.0
1.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
8
64
1.26
0.27
2.5
1.6
nmol/l
46.0
40.5
—
8
64
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
64
1.26
0.27
1.3
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
29
253
1.16
0.27
2.0
2.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
28
245
1.15
0.25
1.8
1.6
—
—
—
0
0
(1002224) Polysomnography panel
14
114
1.24
0.25
1.1
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
76
1.19
0.25
3.2
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
91
0.76
0.22
1.0
1.3
—
—
—
0
0
(4281824)
5
40
1.25
0.22
1.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
41
1.22
0.22
1.0
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
22
192
1.15
0.21
3.6
2.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
52
1.16
0.19
1.0
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
80
1.13
0.15
3.2
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
81
1.11
0.15
3.2
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
81
1.11
0.15
3.2
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
82
1.10
0.15
3.2
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
115
1189
0.95
0.14
3.4
2.8
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
14
125
1.12
0.10
1.6
1.9
mg/l
5.3
3.5
0.69
14
93
(3011288) Drugs identified in Urine by Screen method
6
55
1.09
0.09
4.0
1.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
32
303
1.06
0.08
1.5
1.7
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
9
84
1.07
0.07
8.1
3.0
mg/l
2.1
1.5
—
9
76
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
35
356
0.98
0.00
5.4
4.4
%
31.4
31.6
0.04
28
231
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
114
0.96
0.00
1.3
1.5
—
—
—
0
0
(4034850)
10
96
1.04
0.00
20.7
9.7
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(4133840)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
19.2
—
0
7
(3042733) HLA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
5.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
7
0.00
0.00
0.0
3.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
50
1.00
0.00
1.2
1.6
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
70.1
—
0
5
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_PANNICULITISNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_PANNICULITISNAS | 1.38 [1.15, 1.66] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.527 |
During the follow-up period (1.1.1998 — 31.12.2019), 280 out of 1244 females with M13_PANNICULITISNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_PANNICULITISNAS | 1.738 [1.29, 2.34] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 139 out of 552 males with M13_PANNICULITISNAS died.
Mortality risk
Mortality risk for people of age
years, who have M13_PANNICULITISNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.178% | 0.309% |
| 5 | 0.897% | 1.926% |
| 10 | 2.107% | 4.525% |
| 15 | 4.121% | 8.675% |
| 20 | 7.064% | 14.637% |
Relationships between endpoints
↥Index endpoint: M13_PANNICULITISNAS – Panniculitis, unspecified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data